SCHEMBL24312439

SCHEMBL24312439

O=C(NCCCCOc1cnc2ccc(Br)cc2c1)OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MAPT P10636 1/20 0.47
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TGM2 P21980 1/20 0.46
KEAP1 Q14145 2/20 0.44
NFE2L2 Q16236 2/20 0.44
BRD4 O60885 2/20 0.44
MMP2 P08253 2/20 0.44
MMP9 P14780 2/20 0.44
MMP1 P03956 1/20 0.44
MMP3 P08254 1/20 0.44
MMP7 P09237 1/20 0.44
MMP13 P45452 1/20 0.44
ANPEP P15144 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
AAK1 Q2M2I8 1/20 0.42
ADAM10 O14672 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23217957 0.84 KDM4E (0.40) MAPTLMNA
SCHEMBL24311930 0.81 L3MBTL1 (0.43) HTTL3MBTL1MAPTLMNASMN1; SMN2
SCHEMBL17536575 0.78 L3MBTL1 (0.59) HTTL3MBTL1MAPTLMNASMN1; SMN2
SCHEMBL25258837 0.78 PDGFRB (0.60)
SCHEMBL31052337 0.78 PDGFRB (0.60)
SCHEMBL22515674 0.76 KMT2A (0.50) MAPTLMNASMN1; SMN2AAK1
SCHEMBL30829553 0.74 L3MBTL1 (0.62) HTTL3MBTL1MAPTLMNASMN1; SMN2
SCHEMBL23217950 0.74 CA12 (0.48) HTTLMNAAAK1
SCHEMBL18254066 0.73 HTT (0.81) HTTL3MBTL1MAPTLMNASMN1; SMN2
SCHEMBL26462776 0.73 TAAR1 (0.49) HTTL3MBTL1MAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076905-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-04-14 WO disclosed